Related references
Note: Only part of the references are listed.Combined analysis of serum SAP and PRSS2 for the differential diagnosis of CD and UC
Weifeng Wang et al.
CLINICA CHIMICA ACTA (2021)
PARP inhibitors in gastric cancer: beacon of hope
Yali Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Genetic variants entail type 2 diabetes as an innate immune disorder
Khushdeep Bandesh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2020)
Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies
Julita Machlowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
BDH2 triggers ROS-induced cell death and autophagy by promoting Nrf2 ubiquitination in gastric cancer
Jia-Zhou Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Role of extra cellular proteins in gastric cancer progression and metastasis: an update
Mohammad Reza Abbaszadegan et al.
GENES AND ENVIRONMENT (2020)
High-level expression of PRSS3 correlates with metastasis and poor prognosis in patients with gastric cancer
Fei Wang et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
The extracellular matrix in tumor progression and metastasis
Johannes A. Eble et al.
CLINICAL & EXPERIMENTAL METASTASIS (2019)
CTBP1 and metabolic syndrome induce an mRNA and miRNA expression profile critical for breast cancer progression and metastasis
Paula L. Farré et al.
Oncotarget (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances
Hao Huang
SENSORS (2018)
Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer
Fei Wang et al.
HUMAN PATHOLOGY (2017)
Cancer-associated fibroblasts induce metalloprotease-independent cancer cell invasion of the basement membrane
Alexandros Glentis et al.
NATURE COMMUNICATIONS (2017)
Gastric cancer and related epigenetic alterations
Trupti N. Patel et al.
ECANCERMEDICALSCIENCE (2017)
RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma
Fei Wang et al.
ONCOTARGET (2016)
The metastasis-promoting roles of tumor-associated immune cells
Heath A. Smith et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Activated microglia enhance neurogenesis via trypsinogen secretion
Angeliki M. Nikolakopoulou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Trypsin-2 Enhances Carcinoma Invasion by Processing Tight Junctions and Activating ProMT1-MMP
Suvi-Tuuli Vilen et al.
CANCER INVESTIGATION (2012)
Tumour-Associated Trypsin Inhibitor TATI Is a Prognostic Marker in Colorectal Cancer
Selja Koskensalo et al.
ONCOLOGY (2012)
FoxQ1 Overexpression Influences Poor Prognosis in Non-Small Cell Lung Cancer, Associates with the Phenomenon of EMT
Jian Feng et al.
PLOS ONE (2012)
Identification and validation of genes involved in gastric tumorigenesis
Thangarajan Rajkumar et al.
CANCER CELL INTERNATIONAL (2010)
Intracellular-co-localization of trypsin-2 and matrix metalloprotease-9: Possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma
Suvi-Tuuli Vilen et al.
EXPERIMENTAL CELL RESEARCH (2008)
Matrix metalloproteinases in inflammatory bowel disease: Boon or a bane?
Anupama Ravi et al.
INFLAMMATORY BOWEL DISEASES (2007)
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis
Heiko Witt et al.
NATURE GENETICS (2006)
In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis
JY Qian et al.
CANCER RESEARCH (2005)
Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer:: Prognostic study on tissue and serum
A Paju et al.
CLINICAL CANCER RESEARCH (2004)
Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1,-8,-13) and stromelysin-1 (MMP-3) and degrades type I collagen
M Moilanen et al.
BIOCHEMISTRY (2003)
Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer
H Yamamoto et al.
JOURNAL OF PATHOLOGY (2003)